SEC Form 4 · accession 0001127602-15-004354
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Haluska
Officer — SVP, Clinical R&D, CMO
Period of report
Feb 2, 2015
Accepted (ET)
Feb 4, 2015 · 4:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2015 | M | 29,334 | $0.00 | A | 124,633 | D | |
| Common StockF2 | Feb 2, 2015 | S | 16,134 | $6.3287 | D | 108,499 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4,F5 | — | Feb 2, 2015 | M | 29,334 | D | — | Jan 31, 2024 | Common Stock | 29,334 | 58,666 | D |
Explanation of responses
- F1Shares were acquired upon vesting of restricted stock units awarded on January 31, 2014.
- F2Represents shares withheld to satisfy witholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
- F3Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- F4The restricted stock units vest as to one-third of the units on each of the first, second and third anniversaries of the date of the award (January 31,2014).
- F5The restricted stock units vested on January 31, 2015.